Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development

Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development

Lysophosphatidic acid (LPA) is a ubiquitous lysophospholipid and one of the main membrane-derived lipid signaling molecules. LPA acts as an autocrine/paracrine messenger through at least six G protein-coupled receptors (GPCRs), known as LPA1–6, to induce various cellular processes including wound he...

Full description

Saved in:

Bibliographic Details
Main Authors:	Silvia Anahi Valdés-Rives, Aliesha González-Arenas
Format:	Article
Language:	English
Published:	Wiley 2017-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2017/9173090
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer
by: Ming Quan, et al.
Published: (2017-03-01)

Targeting Lysophosphatidic Acid Ameliorates Dyslipidemia in Familial Hypercholesterolemia
by: Zhiyong Du, et al.
Published: (2025-01-01)

Role of Lysophosphatidic Acid in Neurological Diseases: From Pathophysiology to Therapeutic Implications
by: Simona Dedoni, et al.
Published: (2025-04-01)

Lysophosphatidic acid signaling: Transmembrane modulators in the central nervous system
by: Alexandra Polyzou, et al.
Published: (2026-03-01)

Lysophosphatidic acid selectively modulates excitatory transmission in hippocampal neurons
by: Nicola Brandt, et al.
Published: (2025-08-01)

Lysophosphatidic Acid (LPA) Signaling in Human and Ruminant Reproductive Tract
by: Izabela Wocławek-Potocka, et al.
Published: (2014-01-01)

Role of inflammation, autotaxin and lipoprotein (a) in degenerative aortic valve stenosis in patients with coronary artery disease
by: A. L. Burdeynaya, et al.
Published: (2021-03-01)

Deficiency of lysophosphatidic acid receptor 3 decreases erythropoietin production in hypoxic mouse kidneys
by: Nan Yin, et al.
Published: (2024-11-01)

Lysophosphatidic acid 2 alleviates deep vein thrombosis via protective endothelial barrier function
by: Bai Ruifeng, et al.
Published: (2025-02-01)

Vasoprotective effects of lysophosphatidic acid inhibit vascular injury caused by SARS-CoV-2 infection
by: Fumitaka Muramatsu, et al.
Published: (2025-07-01)

A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
by: Richell Booijink, et al.
Published: (2022-07-01)

A novel strategy for sorafenib-resistant hepatocellular carcinoma: autotaxin Inhibition by PF-8380
by: Bong Jun Kwak, et al.
Published: (2025-03-01)

Design and bioactivity evaluation of a novel autotaxin inhibitor with anti-hepatic fibrosis effects
by: Yuzheng Liu, et al.
Published: (2025-04-01)

Hepatic AKAP1 deficiency exacerbates diet-induced MASLD by enhancing GPAT1-mediated lysophosphatidic acid synthesis
by: Linjie He, et al.
Published: (2025-05-01)

The effect of lysophosphatidic acid on myometrial contractility and the mRNA transcription of its receptors in the myometrium at different stages of endometrosis in mares
by: Katarzyna Karolina Piotrowska-Tomala, et al.
Published: (2024-12-01)

Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21
by: Yunzhou Dong, et al.
Published: (2017-01-01)

LPA<sub>3</sub>: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites
by: K. Helivier Solís, et al.
Published: (2024-12-01)

Validity of serum autotaxin and Doppler ultrasound as noninvasive markers of esophageal varices in patients with liver cirrhosis
by: Doaa El Wazzan, et al.
Published: (2025-01-01)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023-10-01)

Correlation between serum autotaxin levels and optic neuropathy in early diabetic retinopathy: a case-control study
by: Wenjun Chen, et al.
Published: (2025-05-01)

Cerebrospinal fluid levels of sortilin-1, lipocalin-2, autotaxin, decorin and interleukin-33 in patients with idiopathic intracranial hypertension
by: Ahmet Dündar, et al.
Published: (2022-10-01)

Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
by: Jeffrey J Swigris, et al.
Published: (2021-01-01)

Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)
by: Kevin K Brown, et al.
Published: (2019-10-01)

C/EBPβ Isoforms Expression in the Rat Brain during the Estrous Cycle
by: Valeria Hansberg-Pastor, et al.
Published: (2015-01-01)

Sexual Dimorphism in the Regulation of Estrogen, Progesterone, and Androgen Receptors by Sex Steroids in the Rat Airway Smooth Muscle Cells
by: Abraham Zarazúa, et al.
Published: (2016-01-01)

Regulation of cancer by inflammasomes: from inflammation to tumorigenesis
by: Shivani Malvankar, et al.
Published: (2025-07-01)

Mechanistic Perspectives of Maslinic Acid in Targeting Inflammation
by: Wei Hsum Yap, et al.
Published: (2015-01-01)

Genetic mechanisms of disorders in the metabolism of polyunsaturated fatty acids in the development of chronic inflammation in bronchial asthma
by: O. Yu. Kytikova, et al.
Published: (2025-07-01)

Inflammation, Immunity, and Cancer
by: Rajesh Singh, et al.
Published: (2017-01-01)

Exosomes in inflammation and cancer: from bench to bedside applications
by: Shiyuan Huang, et al.
Published: (2025-06-01)

The influence of the microbiota on immune development, chronic inflammation, and cancer in the context of aging
by: Taylor N. Tibbs, et al.
Published: (2019-05-01)

Dynamic changes of the immune microenvironment in the development of gastric cancer caused by inflammation
by: Siyuan Gan, et al.
Published: (2024-09-01)

Interaction of Dietary Fatty Acids with Tumour Necrosis Factor Family Cytokines during Colon Inflammation and Cancer
by: Jiřina Hofmanová, et al.
Published: (2014-01-01)

Development of a New Salt of Piperine with Toluene Sulfonic Acid and Its Anti-Inflammation Effect In Vivo
by: Ilma Nugrahani, et al.
Published: (2024-11-01)

Biomarkers of Inflammation in Obesity-Psoriatic Patients
by: Carmen Rodríguez-Cerdeira, et al.
Published: (2019-01-01)

Midkine (MDK) in cancer and drug resistance: from inflammation to therapy
by: Berna Yıldırım, et al.
Published: (2025-06-01)

From periodontal inflammation to oral cancer: the impact of smokeless tobacco
by: Delfin Lovelina Francis, et al.
Published: (2025-05-01)

Inflammation, microbiota, and pancreatic cancer
by: XiaoLiang Chen, et al.
Published: (2025-02-01)

Oxidative Stress and Inflammation in Cancer
by: Daniela Sorriento
Published: (2024-11-01)

Platelets, thrombo-inflammation and cancer
by: E. V. Slukhanchuk, et al.
Published: (2022-01-01)